492a and 492c were two strains of Pseudomonas aeruginosa isolated from the sputum of a patient with cystic fibrosis. The strains were closely related but expressed different antibiograms. 492c was hypersensitive (10-100 times more sensitive than 492a) to the p-lactam antibiotics carbenicillin, methicillin, flucloxacillin, mecillinam and cefuroxime and the non-fj-lactam, nalidixic acid. 492c also showed enhanced sensitivity (4-8 times more sensitive than 492a) to chloramphenicol, trimethoprim and novobiocin. 492a and PA08 expressed similar levels of antibiotic resistance, except for trimethoprim, to which 492a was five times more sensitive than P A 0 8 . Two genes associated with antibiotic hypersensitivity were mapped in the 30 min region of the chromosome, by means of R68.45-mediated plate matings between a Leu-mutant of 492c and PA08, followed by transductional analysis using phage F116L. The first of these genes, blsA1, was closely linked to nalB, and in a P A 0 background, was associated with hypersensitivity to the p-lactams and a moderate increase in sensitivity to chloramphenicol, trimethoprim, nalidixic acid and novobiocin. A further increase in sensitivity to the latter three antibiotics was associated with the second gene, tpsAI, which mapped between ser-3 and hisV. This gene could also be transferred to P A 0 from 492a, thus 492c could have arisen from 492a in viz7o following a single chromosomal mutation at the blsA locus. Isolation of a blsA mutant of PA0969 provided further evidence for this theory.
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I N T R O D U C T I O N
One of the characteristics most commonly associated with Pseudomonas aeruginosa is an intrinsic resistance to antimicrobial agents, in particular, the 0-lactam antibiotics. Indeed, this property is generally held responsible for the emergence of P. aeruginosa in the last three decades as a clinically important opportunist pathogen.
The development of carbenicillin, the first semi-synthetic penicillin with significant antipseudomonas activity, was a significant advance in chemotherapy. However, the minimal inhibitory concentration (MTC) of carbenicillin for P. aeruginosa is generally 25-50 pg ml- (Knudsen et al., 1967) , which is beyond the levels attainable in soft tissues, e.g. the lung (Marks et al., 1971) . May & Ingold (1972) reported that strains of P. aeruginosa isolated from sputum were often considerably more sensitive to carbenicillin than isolates from other sources. In a study involving 11 1 sputum isolates from patients with cystic fibrosis (CF), chronic bronchitis and bronchiectasis, they found that 35% of strains were sensitive to 6 pg carbenicillin ml-and some had MICs as low as 0-7 pg m1-I. et al. (1979) reported a study on antibiotic susceptibilities of mucoid and non-mucoid strains of P. aeruginosa. They compared 47 mucoid with 71 non-mucoid isolates on the basis of sensitivities to 18 antibiotics and concluded that both groups could be divided into two distinct classes on this basis. Class A contained strains significantly more resistant to antibiotics such as the aminoglycosides and tetracycline, than those strains allocated to Class B.
While studying the association of P. aeruginosa with chronic respiratory infection in CF patients, we have also reported the isolation of strains unusually sensitive (hypersensitive) to a range of antibiotics including the p-lactams carbenicillin, azlocillin, methicillin and also to trimethoprim (Irvin et al., 1981) . The carbenicillin MICs of these strains were < 1 pg ml-and thus comparable with those reported by May & Ingold (1972) . In addition, we reported that hypersensitive and 'normal' isolates could be obtained from the same sputum specimen and that these strains were invariably of the same pyocin type, indicating a close relationship.
Recently, there has been an increasing interest in the genetic basis of virulence in P. aeruginosa and various potential virulence factors have been mapped using the genetically characterized strain, PAO. For example, several chromosomal genes involved in exotoxin A production have been mapped following isolation of toxin-deficient P A 0 mutants, and the use of classical genetic techniques (Gray & Vasil, 1981a; Hanne et al., 1983) . Similarly, a chromosomal gene controlling phospholipase C production has been identified (Gray & Vasil, 1, 981 b) . Both of these potential virulence factors are normally expressed in PAO, but others may be expressed only following a mutation, for example, alginate production leading to a mucoid phenotype which is so common in P. aeruginosa isolated from the sputa of C F patients. Mucoid mutants of P A 0 have been isolated in uitro and two chromosomal loci involved in the control of alginate synthesis have been mapped (Govan & Fyfe, 1978; Fyfe & Govan, 1980 
unpublished).
A third approach to the genetic analysis of virulence involves the transfer of the relevant gene(s) from a clinical isolate into a P A 0 background. This approach is applicable to both chromosomally-encoded and plasmid-encoded characteristics, and has been used in the genetic analysis of extracellular protease production (Wretlind et al., 1983) and transposable antibiotic resistance (Sinclair & Holloway, 1982) .
In the course of studying the intrinsic antibiotic resistance of P. aeruginosa strain PAO, various loci associated with this characteristic have been mapped on the chromosome (Mills & Holloway, 1976; Okii et al., 1983; Matsumoto & Terawaki, 1982) . Functional aspects of the P. aeruginosa outer membrane have been examined using an antibiotic 'supersusceptible' mutant of strain 799 (Zimmerman, 1980; Angus et al., 1982; Darveau & Hancock, 1983) . However, genetic analysis of this strain proved unsuccessful (Angus et al., 1982) .
The genetic basis of antibiotic hypersensitivity as expressed in clinical isolates of P. aeruginosa has not, to our knowledge, been reported. May & Ingold (1972) postulated that the normal resistance to carbenicillin might be plasmid-encoded, and that this plasmid may sometimes be lost during growth in the respiratory tract. However, no evidence was presented to support this hypothesis. The present paper describes the genetic mapping of antibiotic hypersensitivity in the clinical isolate 492c (Irvin et al., 1981) by means of inter-strain crosses with suitably marked P A 0 recipients, followed by transductional analysis using phage F116L (Krishnapillai, 1971) . A preliminary report of this work has been presented (Fyfe & Govan, 1983) .
M E T H O D S
Bucreriu and bacteriophages. The bacterial strains used in this study are shown in Table 1 . Donor strains carrying the plasmid R68.45 were constructed according to Haas & Holloway (1 976). Phage F116L (Krishnapillai, 1971 ) was used for transduction and F116c for strain construction.
Media and culturd conditions. Nutrient broth (NB), nutrient agar (NA), and minimal agar have been described previously (Fyfe & Govan, 1980) . Amino acid supplements were added at a concentration of 1 mM. , and all cultures were incubated at 37 "C, unless stated otherwise.
Isolation uf mutants. Auxotrophic mutants were isolated after EMS mutagenesis (Watson & Holloway, 1976 ) and carbenicillin enrichment (Watson & Holloway, 1978) .
Carbenicillin-hypersensitive mutants were isolated following EMS mutagenesis and screening of colonies by replica plating onto DSTA plates containing 5 pg carbenicillin ml-I .
Antibiotic sensitiritv testing. Exponential phase N B cultures were diluted in physiological saline to a concentration of 10' organisms ml-'. A multiple inoculator (Mast) was used to dispense samples (containing 10'-103 cells)
onto DSTA plates appropriately supplemented with the antibiotics. The MIC was read as the lowest concentration of antibiotic that caused complete growth inhibition after 18 h incubation at 37 "C. PIate rnatings. The procedure used was that described by Stanisich & Holloway (1972) . Prior to inter-strain matings, NB cultures of the recipient strains were incubated for 18 h at 43 "C (Rolfe & Holloway, 1966) .
Transductions. These were performed according to the method of Krishnapillai (1971) .
R E S U L T S
A n t ibio t ic sensit ir it ies It has previously been reported that 492a and 492c differ in their sensitivities to carbenicillin, azlocillin, p i p e r a c i h , ticarcillin, methicillin, tetracycline and trimethoprim (Irvin eta/., 198 1) .
We determined the MICs of an extended range of antibiotics for 492a and 492c, and the results are shown in Table 2 . Strain P A 0 8 was also included to confirm that the MICs obtained for this strain were comparable with 492a and not the hypersensitive 492c. However, 492a was five times more sensitive to trimethoprim than PA08. * P A 0 8 is resistant to streptomycin due to the str-I locus.
ampicillin, cefoxitin and cephaloridine. Increased sensitivity to trimethoprim was confirmed for 492c, and also noted for nalidixic acid and novobiocin. N o differences between 492a and 492c were observed for rifampicin, streptomycin, gentamicin, tobramycin or kanamycin.
Transfer of' antibiotic hypersensitirity ,from 492c to P A 0 Figure 1 is a chromosome map of P. aeruginosa P A 0 showing the locations of markers relevant to this study. A donor derivative of 492c was prepared by isolating a Leu-mutant, and
Antibiotic hypersensitivity in P. aeruginosa 829 transferring R68.45 into this strain. Plate matings were performed between 492c Leu-(R68.45) and the multiple-marker recipient PA0222. Selection was made for each of the auxotrophic markers and 100 recombinants for each marker were scored for co-inheritance of cefuroxime sensitivity (on DSTA plus 100 pg cefuroxime ml-I ) . Increased sensitivity to cefuroxime rather than carbenicillin was chosen initially to avoid any problems associated with the inheritance of R68.45 by some of the recombinants (R68.45 codes for a type IIIa P-lactamase which is active against carbenicillin but not cefuroxime). Recombinant analysis revealed that 56 % of the met-28' colonies were sensitive to 100 pg cefuroxime ml-a n d likewise 20% of the trp-6+ colonies.
Less than 1 % of the recombinants for the other markers, i.e. ilv-226, his-4,lys-12 and pro-82 had co-inherited this characteristic. In order to map the locus associated with increased cefuroxime sensitivity more precisely, a plate mating was performed between 492c Leu -(R68.45) and . Selection was made for both auxotrophic markers and recombinants scored for both cefuroxime and trimethoprim sensitivity (on DSTA plus 100 pg trimethoprim ml-I). The results of this recombinant analysis are shown in Table 3 , and indicate that cefuroxime sensitivity (CEF") and trimethoprim sensitivity (TPs) do not always cosegregate. All CEFs recombinants were TPS, but a percentage of the TPs colonies were CEFJ.
The MICs for representatives of each recombinant class, i.e. CEFs TPs, CEFr TPs and CEF' TPr, were determined using those antibiotics to which 492c is hypersensitive, i.e. carbenicillin, methicillin, flucloxacillin, mecillinam, cefuroxime, chloramphenicol, trimethoprim, nalidixic acid and novobiocin.
All CEFJ TPJ recombinants (three tested) were indistinguishable from PA08 on the basis of MICs to these antibiotics. The CEFs TPs group (eight tested) could be subdivided on the basis of their trimethoprim, nalidixic acid and novobiocin MICs. Three recombinants were very sensitive to these antibiotics with trimethoprim and novobiocin MICs of 10 pg ml-l , and a nalidixic acid MIC of 5 pg ml-I . The other CEFs TPs recombinants were moderately sensitive with the following MICs : trimethoprim 60 pg ml -l , novobiocin 50 pg ml-l , nalidixic acid 20 pg ml-l . All eight recombinants were equally sensitive to the p-lactam antibiotics and chloramphenicol, and with the exception of cefuroxime were as sensitive as 492c. The third class of recombinant, CEF' TPs (five tested), displayed moderate sensitivity to trimethoprim, nalidixic acid and novobiocin, with MICs of 60 pg ml-l, 20 pg ml-and 100 pg ml-I, respectively .
From these results, we postulated that the antibiotic hypersensitive phenotype of 492c is determined by two separate genes, both linked to met-28 and ilu-202, when transferred into PAOS. We propose to call these genes blsA2, coding for hypersensitivity to certain p-lactams and a moderate sensitivity to trimethoprim, nalidixic acid and novobiocin; and tpsAl coding for increased sensitivity to the latter three antibiotics but not the P-lactams. Table 4 shows the relevant MIC values for PA08 and three typical recombinant strains PAJl (blsAI tpsAi), PAJ2 (blsA1) and PAJ3 (tpsAI).
Transfer of' tpsA I .from 492a to P A 0 8 As shown in Table 2 , the trimethoprim MIC for 492a is fivefold less than for PA08. In addition, the increased sensitivity of 492c to trimethoprim, compared with 492a (eightfold), is of the same order as the MIC difference between PAJl and PAJ3 (sixfold) (see Table 4 ). On this basis, we proposed that tpsAl is present in both 492a and 492c, and that the antibiotic hypersensitivity of the latter strain can be explained by a mutation at the blsA locus, i.e. there is only a single gene difference between 492a and 492c accounting for antibiotic hypersensitivity.
Using the mapping procedure already described for 492c, a donor derivative of 492a [492a Leu-(R68.45)] was plate mated with PA08, and the met+ and ilu+ recombinants scored on DSTA containing either 100 pg trimethoprim ml-I or 100 pg cefuroxime ml-l. As expected, a proportion of recombinants failed to grow well on trimethoprim, though all grew well on cefuroxime.
Mapping of blsA and tpsA by transduction using phage F116L From the plate mating results, it was possible to assign approximate chromosomal locations to blsAl and tpsAl relative to iiv-202 and met-28 (see Fig. 2 ). However, to map these loci more precisely with respect to other markers in the 30min region, transductional analysis was performed.
In the case of blsAI, a preparation of F116L was grown on PAJ2 and used to transduce recipient strains carrying the auxotrophic markers met-28 (PA08), iiu-202 (PA08), proCI3O (PA0969) and pyrB.72 (PA04). Selection was made for these markers and cotransduction of blsAl scored on DSTA plus 5 pg carbenicillin ml-*.
In the case of tpsAI, transducing preparations of F116L could not be propagated on any recombinants containing this marker, as they did not appear to support vegetative growth. However, tpsA1 strains retained the receptors for this phage as they were good recipients in F116L-mediated transductions, so in order to map this locus, an ilv-202 tpsAI derivative, PAJB, was constructed (via the intermediate strain PAJS) and used as recipient in transductions mediated by F116L propagated on either PAO1, PA02 (ser-3) or GMA 037 (hisV5037). In each case selection was made for ilv+ transductants and these were scored for co-inheritance of tpsA+ and where appropriate, the unselected auxotrophic markers. Figure 3 shows the locations obtained for blsA and tpsA.
Isolution of a blsA mutant of PA0969 Working on the hypothesis that 492c could have arisen from 492a by a single step mutation at the blsA locus, we postulated that a similar blsA mutant could be isolated from a P A 0 strain. PA0969 was mutagenized with EMS and the potential mutant colonies screened for hypersensitivity to carbenicillin by replica plating to DSTA plates containing 5 pg carbenicillin ml -'.
Antibiotic hjtpersmsitirGty in P. aeruginosa
From approximately 5000 colonies screened, one failed to grow on medium containing carbenicillin. Fortuitously, this mutant (PA065 1 1) exhibited a similar antibiogram to the blsAl recombinants, i.e. PA065 1 1 was highly sensitive to carbenicillin, moderately sensitive to cefuroxime, trimethoprim, nalidixic acid, novobiocin and chloramphenicol, but remained resistant to cefoxitin, cephaloridine and benzyl penicillin. However, PA065 1 1 was more resistant to methicillin, mecillinam and flucloxacillin than a bIsA1 transductant of PA0969. F116L transductions revealed 33% cotransduction between proC and the mutant locus. Furthermore, when F116L propagated on PAJ2 was used to transduce PA0651 1, selecting for proC+, < 0.5% of the transductants were able to grow on 5 pg carbenicillin ml-l , indicating a very close linkage between bLsA1 and the P A 0 mutation, which, on this basis, we have designated blsA2.
Relationship between blsA and naLB Rella & Haas (1982) have described a class of mutants (nalB) in strain P A 0 which are resistant to nalidixic acid, novobiocin, carbenicillin and various other p-lactams. We examined two nalB mutants PA06002 (na1BQ) and PA06006 (naIB9) to determine whether they showed increased resistance to cefuroxime, trimethoprim, methicillin and chloramphenicol. Both strains showed increased resistance to all four antibiotics with the following relative MICs with respect to PA0969: cefuroxime, x 3; trimethoprim, x 6; methicillin, x 5 ; chloramphenicol, x 10, nalB has been mapped at 32 min on the P A 0 chromosome, distal to pyrB using G 101 transduction (Rella & Haas, 1982) , so we determined the location of blsA2 with respect to this locus, using strains PA0651 1 and PA06002. In order to perform reciprocal transductions, a proC derivative of PA06002 (PA06524) and a proC+ derivative of PA06511 (PA06526) were constructed using F116c. Reciprocal transductions using F116L were performed between the blsA and nalB strains, in each case selecting for Pro+ transductants and scoring for blsA and nalB on DSTA plates containing 5 pg and 50 pg carbenicillin ml-l . The results obtained are shown in Table 5 , and suggest that blsA and nalB are separate, but closely linked loci, the gene order being pro C-nalB-blsA .
DISCUSSION
Previous genetic studies on the intrinsic resistance of P. aeruginosa strain P A 0 have identified various chromosomal loci associated with this characteristic. Thus we tested the hypothesis that the loss of intrinsic resistance in 492c was due to a chromosomal mutation, rather than loss of a plasmid as suggested by May & Ingold (1972) . Inter-strain crosses between 492c Leu-(R68.45) and PA08 identified two distinct loci, in the 30 min region of the chromosome, associated with antibiotic sensitivity. The first of these, blsA, is associated with sensitivity to the P-lactams carbenicillin, methicillin, flucloxacillin, mecillinam and cefuroxime, and also the non-p-lactams chloramphenicol, trimethoprim, nalidixic acid and novobiocin and cannot be transferred to P A 0 from 492a.
The isolation of a blsA derivative of P A 0 following EMS mutagenesis provides further evidence that 492c could have arisen from 492a in uiuo following a single-step mutation which was then selected out in the lung environment. This mutation-selection mechanism is also responsible for the emergence of mucoid strains of P. aeruginosa during the course of chronic pulmonary infections in CF patients. All strains of P. aeruginosa have the necessary structural genes to synthesize alginate, but these are normally subject to repression. Mutation in a regulator gene close to the major FP2 origin results in derepression of alginate synthesis giving rise to a mucoid strain (Govan & Fyfe, 1978; Fyfe & Govan, 1980 
Three major questions remain to be answered regarding antibiotic hypersensitivity associated with respiratory isolates. Firstly, whether all such isolates have the same mutation as 492c or whether they form a genetically heterogeneous group. We have examined several pairs of strains (i.e. hypersensitive and 'normal' from the same sputum specimen) isolated from different patients on the basis of antibiotic sensitivities and in general, the antibiograms have been similar to 492a and 492c (results not shown). Genetic analysis of one other hypersensitive strain gave identical results to those obtained with 492c, even though this strain was isolated from a different patient and was of a different pyocin type. However, further work is required to determine whether the blsA locus is the only one involved in clinically associated antibiotic hypersensitivity.
Secondly, we would like to know the structural basis of this characteristic. We have previously reported that 492c has two extra outer membrane proteins when compared with 492a (Irvin et al., 1981) , but further studies have failed to confirm that these are associated with antibiotic sensitivity .
Several studies on the structural basis of antibiotic hypersensitivity in P. aeruginosa have been reported (Noguchi et al., 1980; Curtis et ul., 1981; Angus et al., 1982; Zimmerman, 1980; Kropinski et al., 1982; Darveau et al., 1983) and these have suggested that increased permeability of the cell envelope is responsible for this characteristic. In the case of 799/61, a 'supersuscepti ble' mutant of strain 799 (Zimmerman, 1979) , alterations in the LPS composition have been detected (Kropinski et al., 1982; Darveau et al., 1983) . Similar mutants (enrA) have been reported in Escherichia coli (Grundstrom et al., 1980; Boman et al., 1974) .
The close linkage of blsA and nalB on the P. aeruginosa chromosome is interesting in view of the fact that nalB mutants are more resistant to those antibiotics to which blsA strains are hypersensitive, and it is tempting to speculate that these two loci form part of a gene cluster controlling outer membrane permeability in this organism.
Finally, the clinical and biological significance of antibiotic hypersensitivity remains to be elucidated. Superficially it appears paradoxical that hypersensitive strains arise in patients undergoing aggressive antibiotic therapy, often with /j-lactams. The lung, however, is a
